Brief: Nicox Completes Enrollment Of Adaptive Design Cohort Of NCX470 Mont Blanc Phase 3 Trial

Nicox SA

02/09/2020 06:35

Sept 2 (Reuters) - Nicox SA  NCOX.PA :
    * NICOX COMPLETES ENROLLMENT OF ADAPTIVE DESIGN COHORT OF
NCX 470
MONT BLANC PHASE 3 GLAUCOMA TRIAL
    * DUE TO POTENTIAL DELAYS CAUSED BY COVID-19, COMPANY IS NOT
CURRENTLY PROVIDING A TARGET DATE FOR MONT BLANC TOPLINE RESULTS

Source text for Eikon:  ID:nGNE5xDQ7r 
Further company coverage:  NCOX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))